By the Numbers
Receiving a cancer diagnosis often means navigating numbers, such as estimates of the chance of recurrence. But cancer patients...
Receiving a cancer diagnosis often means navigating numbers, such as estimates of the chance of recurrence. But cancer patients...
Hot on the heels of the FDA’s landmark approval of an anticancer therapeutic for use based on whether a...
Guest Post by William G. Nelson, MD, PhD Editor-in-Chief, Cancer Today Nearly 1.7 million new cancer cases and roughly 600,000...
There is perhaps nothing more painful for parents than receiving a cancer diagnosis for their child. Childhood cancers are...
In recent years, the American Association for Cancer Research (AACR) has expanded its efforts to catalyze advances in cancer...
Members of the AACR Project GENIE consortium presented their first analyses of the data during the Pan-Cancer Genomic Analysis...
May is National Cancer Research Month, during which the American Association for Cancer Research partners with advocacy groups, cancer...
Two studies presented at the AACR Annual Meeting 2017 showed that tumors that have mutations in the proteins isocitrate...
The U.S. Food and Drug Administration (FDA) has approved expanding the use of the immunotherapeutic pembrolizumab (Keytruda) to include...
The AACR has a robust program of educational workshops designed to equip early-career investigators with the knowledge, skills, and...